Green tea: A promising anticancer agent for renal cell carcinoma

Food Chemistry

Volumn 122, Issue 1, 2010, Pages 49-54

  Carvalho, Márcia ^a,b   Jerónimo, Carmen ^c,d   Valentão, Patrícia ^b   Andrade, Paula B ^b   Silva, Branca M ^a,b  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b Rua do Campo Alegre s n   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antiproliferative activity; Camellia sinensis; Green tea; Polyphenols; Renal cell carcinoma

Indexed keywords

GREEN TEA EXTRACT; POLYPHENOL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; TEA;

CAMELLIA SINENSIS;

EID: 77950593368     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.02.014     Document Type: Article

References (44)

1. Ahmad N., Gupta S., and Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Archives of Biochemistry and Biophysics 376 (2000) 338-346
2. Ahn W.S., Huh S.W., and Bae S.W. Major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, though apoptosis, G1 arrest, and regulation of gene expression. DNA and Cell Biology 22 (2003) 217-224
3. Ahn W.S., Yoo J., and Huh S.W. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. European Journal of Cancer Prevention 12 (2003) 383-390
4. Albrecht D.S., Clubbs E.A., Ferruzzi M., and Bomser J.A. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chemico-Biological Interactions 171 (2008) 89-95
5. Amato R.J. Chemotherapy for renal cell carcinoma. Seminars in Oncology 27 (2000) 177-186
6. Baptista J.A.B., Tavares J.F.P., and Carvalho R.C.B. Comparison of catechins and aromas among different green teas using HPLC/SPME-GC. Food Research International 31 (1998) 729-736
7. Boivin D., Lamy S., Lord-Dufour S., Jackson J., Beaulieu E., Côté M., et al. Antiproliferative and antioxidant activities of common vegetables: A comparative study. Food Chemistry 112 (2009) 374-380
8. Carlson J.R., Bauer B.A., Vincent A., Limburg P.J., and Wilson T. Reading the tea leaves: Anticarcinogenic properties of (-)-epigallocatechin-3-gallate. Mayo Clinic Proceedings 82 (2007) 725-732
9. Carvalho M., Hawksworth G., Milhazes N., Borges F., and Monks T.J. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: An in vitro study using rat and human renal proximal tubular cells. Archives of Toxicology 76 (2002) 581-588
10. Chen D., and Dou Q.P. Tea polyphenols and their roles in cancer prevention and chemotherapy. International Journal of Molecular Sciences 9 (2008) 1196-1206
11. Chen L., Lee M., Li H., and Yang C.S. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metabolism and Disposition 25 (1997) 1045-1050
12. Chen Z.P., Schell J.B., Ho C.T., and Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Letters 129 (1998) 173-179
13. Chung F.L., Wang M., Rivenson A., Iatropoulos M.J., Reinhardt J.C., Pittman B., et al. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: Caffeine as an important constituent. Cancer Research 58 (1998) 4096-4101
14. Costa R.M., Magalhães A.S., Pereira J.A., Andrade P.B., Valentão P., Carvalho M., et al. Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: A comparative study with green tea (Camellia sinensis). Food and Chemical Toxicology 47 (2009) 860-865
15. Fassina G., Venè R., Morini M., Minghelli S., Benelli R., Noonan D.M., et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Research 10 (2004) 4865-4873
16. Gu B., Ding Q., Xia G., and Fang Z. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncology Reports 21 (2009) 635-640
17. Huang M.T., Xie J.G., Wang Z.Y., Ho C.T., Lou Y.R., Wang C.X., et al. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: Demonstration of caffeine as a biologically important constituent of tea. Cancer Research 57 13 (1997) 2623-2629
18. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Smigal C., et al. Cancer statistics, 2009. CA: A Cancer Journal for Clinicians 59 (2009) 225-249
19. Ju J., Lu G., Lambert J.D., and Yang C.S. Inhibition of carcinogenesis by tea constituents. Seminars in Cancer Biology 17 (2007) 395-402
20. Katiyar S.K. Matrix metalloproteinases in cancer metastasis: Molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocrine, Metabolic and Immune Disorders Drug Targets 6 (2006) 17-24
21. Marques V., and Farah A. Chlorogenic acids and related compounds in medical plants and infusions. Food Chemistry 113 (2009) 1370-1376
22. Mathew A., Devesa S.S., Fraumeni J.F., and Chow W.H. Global increases in kidney cancer incidence, 1973-1992. European Journal of Cancer Prevention 11 (2002) 171-178
23. Moderno P.M., Carvalho M., and Silva B.M. Recent patents on Camellia sinensis: Source of health promoting compounds. Recent Patents on Food, Nutrition and Agriculture 1 (2009) 182-192
24. Motzer R.J., Mazumdar M., Bacik J., Russo P., Berg W.J., and Metz E.M. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. Journal of Clinical Oncology 18 (2000) 1928-1935
25. Qin J., Xie L.P., Zheng X.Y., Wang Y.B., Bai Y., Shen H.F., et al. A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochemical and Biophysical Research Communications 354 (2007) 852-857
26. Ravindranath M.H., Ramasamy V., Moon S., Ruiz C., and Muthugounder S. Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). Evidence-based Complementary and Alternative Medicine 6 (2009) 523-530
27. Rietveld A., and Wiseman S. Antioxidant effects of tea: Evidence from human clinical trials. The Journal of Nutrition 133 (2003) 3285S-3292S
28. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0. Oncology Reports 16 (2006) 943-947
29. Sadava D., Whitlock E., and Kane S.E. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochemical and Biophysical Research Communications 360 (2007) 233-237
30. Seeram N.P., Henning S.M., Niu Y., Lee R., Scheuller H., and Heber D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. Journal of Agricultural and Food Chemistry 54 (2006) 1599-1603
31. Shankar S., Ganapathy S., Hingorani S.R., and Srivastava R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience 13 (2008) 440-452
32. Shankar S., Ganapathy S., and Srivastava R.K. Green tea polyphenols: Biology and therapeutic implications in cancer. Frontiers in Bioscience 12 (2007) 4881-4899
33. Shirakami Y., Shimizu M., Adachi S., Sakai H., Nakagawa T., Yasuda Y., et al. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Science 100 (2009) 1957-1962
34. Stewart A., Mullen W., and Crozier A. On-line high-performance liquid chromatography analysis of the antioxidant activity of phenolic compounds in green and black tea. Molecular Nutrition and Food Research 49 (2005) 52-60
35. Thangapazham R.L., Singh A.K., Sharma A., Warren J., Gaddipati J.P., and Maheshwari R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Letters 245 (2007) 232-241
36. Yamakawa S., Asai T., Uchida T., Matsukawa M., Akizawa T., and Oku N. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Letters 210 (2004) 47-55
37. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., and Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology, Biomarkers and Prevention 7 (1998) 351-354
38. Yang C.S., and Chung J.Y. Growth inhibition of human cancer cell lines by tea polyphenols. Current Medical Practice 2 (1999) 163-166
39. Yang C.S., Lambert J.D., Hou Z., Ju J., Lu G., and Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Molecular Carcinogenesis 45 (2006) 431-435
40. Yang C.S., Lambert J.D., Ju J., Lu G., and Sang S. Tea and cancer prevention: Molecular mechanisms and human relevance. Toxicology and Applied Pharmacology 224 (2007) 265-273
41. Yang G.Y., Liao J., Kim K., Yurkow E.J., and Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19 (1998) 611-616
42. Yang C.S., Liao J., Yang G.Y., and Lu G. Inhibition of lung tumorigenesis by tea. Experimental Lung Research 31 (2005) 135-144
43. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annual Review of Pharmacology and Toxicology 42 (2002) 25-54
44. Yang C.S., Wang X., Lu G., and Picinich S.C. Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nature Reviews. Cancer 9 (2009) 429-439